[
  {
    "ts": null,
    "headline": "AbbVie (ABBV) Stock Falls Amid Market Uptick: What Investors Need to Know",
    "summary": "The latest trading day saw AbbVie (ABBV) settling at $226.22, representing a -1.27% change from its previous close.",
    "url": "https://finnhub.io/api/news?id=6f62619a6910e2390c69c496ec4115ad2c60cca88dfdb0d69d996d9fb28995d1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760564705,
      "headline": "AbbVie (ABBV) Stock Falls Amid Market Uptick: What Investors Need to Know",
      "id": 137101945,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "The latest trading day saw AbbVie (ABBV) settling at $226.22, representing a -1.27% change from its previous close.",
      "url": "https://finnhub.io/api/news?id=6f62619a6910e2390c69c496ec4115ad2c60cca88dfdb0d69d996d9fb28995d1"
    }
  },
  {
    "ts": null,
    "headline": "Enveric Biosciences hires Fish & Richardson to defend patent tied to AbbVie deal",
    "summary": "Investing.com -- Enveric Biosciences (NASDAQ: ENVB) has hired prominent intellectual property law firm Fish and Richardson P.C. to contest a Post-Grant Review (PGR) petition filed by Gilgamesh Pharmaceuticals, which earlier this year agreed to be acquired by AbbVie for up to $1.2 billion, Investing.com has learned.",
    "url": "https://finnhub.io/api/news?id=5481bff4e9828a48d1462a87b37165e784361ab3122e9efbdf6a47897a8e0f97",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760531413,
      "headline": "Enveric Biosciences hires Fish & Richardson to defend patent tied to AbbVie deal",
      "id": 137093924,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Investing.com -- Enveric Biosciences (NASDAQ: ENVB) has hired prominent intellectual property law firm Fish and Richardson P.C. to contest a Post-Grant Review (PGR) petition filed by Gilgamesh Pharmaceuticals, which earlier this year agreed to be acquired by AbbVie for up to $1.2 billion, Investing.com has learned.",
      "url": "https://finnhub.io/api/news?id=5481bff4e9828a48d1462a87b37165e784361ab3122e9efbdf6a47897a8e0f97"
    }
  },
  {
    "ts": null,
    "headline": "Enveric Biosciences Hires IP Powerhouse to Defend Its U.S. Patent with Claims Relevant to Bretisilocin, Recently Acquired by AbbVie in $1.2 Billion Deal",
    "summary": "CAMBRIDGE, Mass., October 15, 2025--Enveric Biosciences (NASDAQ: ENVB) (\"Enveric\" or the \"Company\"), a biotechnology company advancing next-generation neuroplastogenic small molecules to address psychiatric and neurological disorders, today announced that it has hired intellectual property powerhouse Fish and Richardson P.C. to contest a Post-Grant Review (PGR) petition filed by Gilgamesh Pharmaceuticals (Gilgamesh) against Enveric’s issued U.S. Patent No. 12,138,276 (the’276 patent,) entitled,",
    "url": "https://finnhub.io/api/news?id=d2b1be7dd1feedd9e234351b7f0c076cf30e977b7b13a226d9558ea7e2d10b9d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760529600,
      "headline": "Enveric Biosciences Hires IP Powerhouse to Defend Its U.S. Patent with Claims Relevant to Bretisilocin, Recently Acquired by AbbVie in $1.2 Billion Deal",
      "id": 137093925,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "CAMBRIDGE, Mass., October 15, 2025--Enveric Biosciences (NASDAQ: ENVB) (\"Enveric\" or the \"Company\"), a biotechnology company advancing next-generation neuroplastogenic small molecules to address psychiatric and neurological disorders, today announced that it has hired intellectual property powerhouse Fish and Richardson P.C. to contest a Post-Grant Review (PGR) petition filed by Gilgamesh Pharmaceuticals (Gilgamesh) against Enveric’s issued U.S. Patent No. 12,138,276 (the’276 patent,) entitled,",
      "url": "https://finnhub.io/api/news?id=d2b1be7dd1feedd9e234351b7f0c076cf30e977b7b13a226d9558ea7e2d10b9d"
    }
  }
]